Octavio Espinoza At Ligand Pharmaceuticals Capitalizes: Options Exercised, Resulting In $308K

view original post

The latest update on Friday morning shows Ligand Pharmaceuticals shares down by 0.0%, trading at $198.41. At this price, Espinoza’s 2,381 shares are worth $308,116.